Latest Cannabis Science Inc (CBIS) Headlines
Cannabis Science (CBIS) Closes Recently Announced $1 Million PPM Financing To Fund Research and Development In the U.S.A. and Europe; Funding Effort Fully Subscribed
PR Newswire - Fri Mar 07, 9:19AM CST
(CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, closes the recently announced, February 20, 2014, financing for $1,000,000.00 through a private placement with the pricing set at $0.25 per share for Section 144 restricted shares coupled with a two-year warrant for $0.50 per share to comprise a complete unit offering.
Cannabis Capital Corp. (CBCA) Confirms Approval of Name Change with FINRA and Key Executive Appointments; Announces New Trading Symbol 'CBCA'
PR Newswire - Tue Mar 04, 10:26AM CST
Cannabis Capital Corp. (CBCA) fka World Stevia Corp (WSTV) is a Company focused on high-growth acquisitions within the Cannabis Industry.
Cannabis Science (CBIS) Expands into Spanish Market; Specific Focus on Medical Research and Studies
PR Newswire - Fri Feb 28, 9:52AM CST
(OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, announces it has been in confidential negotiations for several months with key players in Spain to expand into the Spanish market to conduct cannabis research and other operations. The initial agreement has been signed and more information will be provided. Spain's population is approximately 47 million and has a significant cannabis and hemp market.
Research Report: AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014
M2 - Mon Feb 24, 3:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/k5svvq/aids_related) has announced the addition of the "AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014" report to their offering. 'AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for AIDS - Related Kaposi's Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for AIDS - Related Kaposi's Sarcoma. Scope - A snapshot of the global therapeutic scenario for AIDS - Related Kaposi's Sarcoma. - A review of the AIDS - Related Kaposi's Sarcoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the AIDS - Related Kaposi's Sarcoma pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction AIDS - Related Kaposi's Sarcoma Overview Therapeutics Development Pipeline Products for AIDS - Related Kaposi's Sarcoma - Overview Pipeline Products for AIDS - Related Kaposi's Sarcoma - Comparative Analysis AIDS - Related Kaposi's Sarcoma - Therapeutics under Development by Companies AIDS - Related Kaposi's Sarcoma - Pipeline Products Glance Clinical Stage Products Early Stage Products AIDS - Related Kaposi's Sarcoma - Products under Development by Companies AIDS - Related Kaposi's Sarcoma - Companies Involved in Therapeutics Development AIDS - Related Kaposi's Sarcoma - Therapeutics Assessment Drug Profiles aldoxorubicin - Drug Profile paclitaxel nanosomal - Drug Profile CS-TATI-1 - Drug Profile interferon alfa-2a biosimilar - Drug Profile interferon alfa-2b - Drug Profile interferon alfa-2a - Drug Profile R&D Progress Featured News & Press Releases Appendix Companies Mentioned Aphios Corporation CytRx Corporation Cannabis Science, Inc. Xiamen Amoytop Biotech Co., Ltd. Biogenomics For more information visit http://www.researchandmarkets.com/research/k5...ds_related About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Cannabis Science Negotiates $1 Million Financing for Progression of Products and Start of Observational Trials
PR Newswire - Thu Feb 20, 9:37AM CST
(OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, has agreed to finance $1 million to satisfy its current capital requirements. Cannabis Science is raising the $1 million through private placement. The pricing is set at $0.25 per share for 144 restricted shares coupled with a one-year warrant for $0.50 per share to comprise a complete unit offering.
Pandora shares start to bounce while Cannabis Science announces partnership with Green Technologies
ACCESSWIRE - Tue Feb 18, 11:29PM CST
Wondering what your next move should be in the market? BullTrends.com can help lead the way. For free access to our complete stock reports, take a few minutes to register with us by clicking this link: http://www.bulltrends.com/
Cannabis Science (CBIS) Signs Partnership Agreement with Michigan Green Technologies, LLC to Focus on Reform and Proper Implementation of Cannabis and Commercial Hemp Programs for the State of Michigan
PR Newswire - Thu Feb 13, 8:36AM CST
Cannabis Science, Inc. (NASD OTC: CBIS), a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, is proud to announce its new partnership with Michigan Green Technologies, LLC that has a broad focus on the reform and proper implementation of state approved cannabis and commercial hemp programs with comprehensive seed to sale process to include cultivation; studies; medical testing; manufacturing; a taxation model; commercial and consumer distribution; education; and clinical research.
Penske Automotive Reports Record Fourth Quarter and Full Year 2013 Results
PR Newswire - Thu Feb 13, 6:33AM CST
Penske Automotive Group, Inc. (NYSE
AG), an international transportation services company, announced today the highest fourth quarter and full year 2013 income from continuing operations and related earnings per share in company history. For the fourth quarter, income from continuing operations attributable to common shareholders increased 19.3% to $61.7 million and related earnings per share increased 19.3% to $0.68 per share when compared to the same period last year.
The Zacks Analyst Blog Highlights:BP, Tesoro, Apache, Anadarko Petroleum and FMC Technologies
PR Newswire - Wed Feb 12, 8:30AM CST
CHICAGO, Feb. 12, 2014 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the BP plc (NYSE:BP-Free Report), Tesoro Corp. (NYSE:TSO-Free Report), Apache Corp. (NYSE:APA-Free Report), Anadarko Petroleum Corp. (NYSE:APC-Free Report) and FMC Technologies Inc. (NYSE:FTI-Free Report).
Economic Benefit of Hemp Legalization Could Be Overestimated: (OTC PINK: HEMP), Cannabis Science Inc. (OTCQB: CBIS), Cannabis Solutions (OTCQB: CANN), Medbox, Inc. (OTC PINK: MDBX)
ACCESSWIRE - Wed Feb 12, 8:29AM CST
Is the legalization of hemp the potential economic windfall some predict?
Mounting Momentum for Marijuana Legalization Benefits 4 Cannabis Penny Stocks
ACCESSWIRE - Tue Feb 11, 9:11AM CST
The simple reality is that every day the chances for the legalization of marijuana in the United States, either recreational or medicinal, is looking better, which means many nascent cannabis companies stand to benefit.
Former Microsoft Exec Predicts Hundreds of Marijuana Stores Open in 5 Years: Plandai Biotechnology's (OTCQB: PLPL), AVT Inc. (OTCPINK: AVTC), Advanced Cannabis Solutions (OTCQB: CANN), Cannabis Science Inc. (NASDAQ OTC: CBIS)
ACCESSWIRE - Fri Feb 07, 11:50AM CST
Imagine your favorite shopping mall with its very own boutique marijuana store.
Unveiling of New Natural-Flavored e-Cigarette Ignites mCig's Stock Volume: mCig Inc. (OTCQB: MCIG), Growlife Inc. (OTCBB: PHOT), Cannabis Science Inc. (OTCQB: CBIS)
ACCESSWIRE - Fri Feb 07, 11:49AM CST
The prospect of the legalization of marijuana coupled with the excitement surrounding e-cigarettes is spurring innovation and new product development daily.
Cannabis Science (CBIS) Collaborates with Patients Out of Time, Inc., a Global Patient Advocacy Organization Dedicated to Educating Health Professionals and the Public about Therapeutic Cannabis
PR Newswire - Wed Feb 05, 11:48AM CST
(NASD OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, provides development consultation and financial support to Patients Out of Time, Inc., the premiere non-profit organization devoted to helping educate the public and healthcare professionals about the safety and effectiveness of medical cannabis. Cannabis Science is pleased to facilitate the critical work of this unique non-profit organization's ongoing conferences, events, workshops and global distribution of leading edge educational content and online resources.
4 Marijuana Penny-Stocks Inch toward Becoming Players: Creative Edge Nutrition Inc.'s (OTC Pink: FITX), Growlife Inc. (OTCBB: PHOT), Cannabis Science Inc. (NASDAQ OTC: CBIS), Hemp Inc. (OTCPINK: HEMP)
ACCESSWIRE - Wed Feb 05, 8:10AM CST
Several marijuana penny stocks are inching closer to the reality of one day becoming major players in the legal-marijuana industry.
Spectra7 Announces Promotion Of Melissa Chee To Vice President Of Corporate Marketing And Product Management
PR Newswire - Tue Feb 04, 8:00AM CST
(TSX-V:SEV) Spectra7 Microsystems Inc. ("Spectra7"), a high performance analog semiconductor company delivering unprecedented speed, resolution and signal fidelity to consumer and wireless infrastructure products, today announced that Melissa Chee has been promoted to Vice President of Corporate Marketing and Product Management for the Company.
Cannabis Science (CBIS) Applauds U.S. Congress on Moving to Legalize Hemp Cultivation and Research; Calls Today for Final Senate Passage of Farm Bill and President's Signature into Law
PR Newswire - Tue Feb 04, 7:52AM CST
Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, is pleased that the U.S. Congress and President Obama appear positioned to approve the first federal law to legalize hemp cultivation and advanced research on a federal level, creating unprecedented opportunities for the Company to pursue patient-based pharmaceutical solutions for patients.
4 Marijuana Stocks Built on Promising Practical Products: AVT Inc. (OTC PINK: AVTC), Advanced Cannabis Solutions (OTCQB: CANN), Medbox, Inc. (OTCPINK Markets: MDBX), Cannabis Science Inc. (NASDAQ OTC: CBIS)
ACCESSWIRE - Mon Feb 03, 8:01AM CST
Bright, shiny and new marijuana stocks with various sundry visions of exploiting the much anticipated legal- marijuana industry are going public every day, with enchanting narratives that can swoon even the most hardcore investors.
CBIS Provides Growth Guidance on its Medicine Dispensing Systems (MDS) Exclusive & Non-Exclusive Agreements
PR Newswire - Mon Feb 03, 7:26AM CST
(NASDAQ OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, provides shareholder clarity and growth guidance for its gross profit sharing exclusive and non-exclusive agreement in select markets with MDS, a subsidiary of Medbox, Inc. Under the terms of the agreement Cannabis Science has a 50/50 gross profit exclusive on any and all MDS equipment sales in Canada and other select markets. Both CBIS and MDS have multiple opportunities in Canada based on recent developments with medical cannabis in that market. Other countries will follow pursuant to the agreement as CBIS moves forward aggressively in Europe and South America.
Medical Marijuana Payment Provider Gets $1.1 Million from Unnamed Private-Equity Firm: MediSwipe Inc. (OTCQB: MWIP), Cannabis Science Inc. (NASDAQ OTC: CBIS), Medical Marijuana Inc. (OTC PINK: MJNA), Growlife Inc. (OTCBB: PHOT)
ACCESSWIRE - Thu Jan 30, 8:44AM CST
Mystery, anticipation and anonymity continue to surround the medical and recreational marijuana industries, especially when it comes to penny stocks.
Cannabis Science (CBIS) Closes Recently Announced $1 Million PPM Financing To Fund Research and Development In the U.S.A. and Europe; Funding Effort Fully Subscribed
PR Newswire - Fri Mar 07, 9:19AM CST
(CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, closes the recently announced, February 20, 2014, financing for $1,000,000.00 through a private placement with the pricing set at $0.25 per share for Section 144 restricted shares coupled with a two-year warrant for $0.50 per share to comprise a complete unit offering.
Cannabis Capital Corp. (CBCA) Confirms Approval of Name Change with FINRA and Key Executive Appointments; Announces New Trading Symbol 'CBCA'
PR Newswire - Tue Mar 04, 10:26AM CST
Cannabis Capital Corp. (CBCA) fka World Stevia Corp (WSTV) is a Company focused on high-growth acquisitions within the Cannabis Industry.
Cannabis Science (CBIS) Expands into Spanish Market; Specific Focus on Medical Research and Studies
PR Newswire - Fri Feb 28, 9:52AM CST
(OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, announces it has been in confidential negotiations for several months with key players in Spain to expand into the Spanish market to conduct cannabis research and other operations. The initial agreement has been signed and more information will be provided. Spain's population is approximately 47 million and has a significant cannabis and hemp market.
Research Report: AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014
M2 - Mon Feb 24, 3:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/k5svvq/aids_related) has announced the addition of the "AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014" report to their offering. 'AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2014', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for AIDS - Related Kaposi's Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for AIDS - Related Kaposi's Sarcoma. Scope - A snapshot of the global therapeutic scenario for AIDS - Related Kaposi's Sarcoma. - A review of the AIDS - Related Kaposi's Sarcoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the AIDS - Related Kaposi's Sarcoma pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction AIDS - Related Kaposi's Sarcoma Overview Therapeutics Development Pipeline Products for AIDS - Related Kaposi's Sarcoma - Overview Pipeline Products for AIDS - Related Kaposi's Sarcoma - Comparative Analysis AIDS - Related Kaposi's Sarcoma - Therapeutics under Development by Companies AIDS - Related Kaposi's Sarcoma - Pipeline Products Glance Clinical Stage Products Early Stage Products AIDS - Related Kaposi's Sarcoma - Products under Development by Companies AIDS - Related Kaposi's Sarcoma - Companies Involved in Therapeutics Development AIDS - Related Kaposi's Sarcoma - Therapeutics Assessment Drug Profiles aldoxorubicin - Drug Profile paclitaxel nanosomal - Drug Profile CS-TATI-1 - Drug Profile interferon alfa-2a biosimilar - Drug Profile interferon alfa-2b - Drug Profile interferon alfa-2a - Drug Profile R&D Progress Featured News & Press Releases Appendix Companies Mentioned Aphios Corporation CytRx Corporation Cannabis Science, Inc. Xiamen Amoytop Biotech Co., Ltd. Biogenomics For more information visit http://www.researchandmarkets.com/research/k5...ds_related About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Cannabis Science Negotiates $1 Million Financing for Progression of Products and Start of Observational Trials
PR Newswire - Thu Feb 20, 9:37AM CST
(OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, has agreed to finance $1 million to satisfy its current capital requirements. Cannabis Science is raising the $1 million through private placement. The pricing is set at $0.25 per share for 144 restricted shares coupled with a one-year warrant for $0.50 per share to comprise a complete unit offering.
Pandora shares start to bounce while Cannabis Science announces partnership with Green Technologies
ACCESSWIRE - Tue Feb 18, 11:29PM CST
Wondering what your next move should be in the market? BullTrends.com can help lead the way. For free access to our complete stock reports, take a few minutes to register with us by clicking this link: http://www.bulltrends.com/
Cannabis Science (CBIS) Signs Partnership Agreement with Michigan Green Technologies, LLC to Focus on Reform and Proper Implementation of Cannabis and Commercial Hemp Programs for the State of Michigan
PR Newswire - Thu Feb 13, 8:36AM CST
Cannabis Science, Inc. (NASD OTC: CBIS), a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, is proud to announce its new partnership with Michigan Green Technologies, LLC that has a broad focus on the reform and proper implementation of state approved cannabis and commercial hemp programs with comprehensive seed to sale process to include cultivation; studies; medical testing; manufacturing; a taxation model; commercial and consumer distribution; education; and clinical research.
Penske Automotive Reports Record Fourth Quarter and Full Year 2013 Results
PR Newswire - Thu Feb 13, 6:33AM CST
Penske Automotive Group, Inc. (NYSE
AG), an international transportation services company, announced today the highest fourth quarter and full year 2013 income from continuing operations and related earnings per share in company history. For the fourth quarter, income from continuing operations attributable to common shareholders increased 19.3% to $61.7 million and related earnings per share increased 19.3% to $0.68 per share when compared to the same period last year. The Zacks Analyst Blog Highlights:BP, Tesoro, Apache, Anadarko Petroleum and FMC Technologies
PR Newswire - Wed Feb 12, 8:30AM CST
CHICAGO, Feb. 12, 2014 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the BP plc (NYSE:BP-Free Report), Tesoro Corp. (NYSE:TSO-Free Report), Apache Corp. (NYSE:APA-Free Report), Anadarko Petroleum Corp. (NYSE:APC-Free Report) and FMC Technologies Inc. (NYSE:FTI-Free Report).
Economic Benefit of Hemp Legalization Could Be Overestimated: (OTC PINK: HEMP), Cannabis Science Inc. (OTCQB: CBIS), Cannabis Solutions (OTCQB: CANN), Medbox, Inc. (OTC PINK: MDBX)
ACCESSWIRE - Wed Feb 12, 8:29AM CST
Is the legalization of hemp the potential economic windfall some predict?
Mounting Momentum for Marijuana Legalization Benefits 4 Cannabis Penny Stocks
ACCESSWIRE - Tue Feb 11, 9:11AM CST
The simple reality is that every day the chances for the legalization of marijuana in the United States, either recreational or medicinal, is looking better, which means many nascent cannabis companies stand to benefit.
Former Microsoft Exec Predicts Hundreds of Marijuana Stores Open in 5 Years: Plandai Biotechnology's (OTCQB: PLPL), AVT Inc. (OTCPINK: AVTC), Advanced Cannabis Solutions (OTCQB: CANN), Cannabis Science Inc. (NASDAQ OTC: CBIS)
ACCESSWIRE - Fri Feb 07, 11:50AM CST
Imagine your favorite shopping mall with its very own boutique marijuana store.
Unveiling of New Natural-Flavored e-Cigarette Ignites mCig's Stock Volume: mCig Inc. (OTCQB: MCIG), Growlife Inc. (OTCBB: PHOT), Cannabis Science Inc. (OTCQB: CBIS)
ACCESSWIRE - Fri Feb 07, 11:49AM CST
The prospect of the legalization of marijuana coupled with the excitement surrounding e-cigarettes is spurring innovation and new product development daily.
Cannabis Science (CBIS) Collaborates with Patients Out of Time, Inc., a Global Patient Advocacy Organization Dedicated to Educating Health Professionals and the Public about Therapeutic Cannabis
PR Newswire - Wed Feb 05, 11:48AM CST
(NASD OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, provides development consultation and financial support to Patients Out of Time, Inc., the premiere non-profit organization devoted to helping educate the public and healthcare professionals about the safety and effectiveness of medical cannabis. Cannabis Science is pleased to facilitate the critical work of this unique non-profit organization's ongoing conferences, events, workshops and global distribution of leading edge educational content and online resources.
4 Marijuana Penny-Stocks Inch toward Becoming Players: Creative Edge Nutrition Inc.'s (OTC Pink: FITX), Growlife Inc. (OTCBB: PHOT), Cannabis Science Inc. (NASDAQ OTC: CBIS), Hemp Inc. (OTCPINK: HEMP)
ACCESSWIRE - Wed Feb 05, 8:10AM CST
Several marijuana penny stocks are inching closer to the reality of one day becoming major players in the legal-marijuana industry.
Spectra7 Announces Promotion Of Melissa Chee To Vice President Of Corporate Marketing And Product Management
PR Newswire - Tue Feb 04, 8:00AM CST
(TSX-V:SEV) Spectra7 Microsystems Inc. ("Spectra7"), a high performance analog semiconductor company delivering unprecedented speed, resolution and signal fidelity to consumer and wireless infrastructure products, today announced that Melissa Chee has been promoted to Vice President of Corporate Marketing and Product Management for the Company.
Cannabis Science (CBIS) Applauds U.S. Congress on Moving to Legalize Hemp Cultivation and Research; Calls Today for Final Senate Passage of Farm Bill and President's Signature into Law
PR Newswire - Tue Feb 04, 7:52AM CST
Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, is pleased that the U.S. Congress and President Obama appear positioned to approve the first federal law to legalize hemp cultivation and advanced research on a federal level, creating unprecedented opportunities for the Company to pursue patient-based pharmaceutical solutions for patients.
4 Marijuana Stocks Built on Promising Practical Products: AVT Inc. (OTC PINK: AVTC), Advanced Cannabis Solutions (OTCQB: CANN), Medbox, Inc. (OTCPINK Markets: MDBX), Cannabis Science Inc. (NASDAQ OTC: CBIS)
ACCESSWIRE - Mon Feb 03, 8:01AM CST
Bright, shiny and new marijuana stocks with various sundry visions of exploiting the much anticipated legal- marijuana industry are going public every day, with enchanting narratives that can swoon even the most hardcore investors.
CBIS Provides Growth Guidance on its Medicine Dispensing Systems (MDS) Exclusive & Non-Exclusive Agreements
PR Newswire - Mon Feb 03, 7:26AM CST
(NASDAQ OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, provides shareholder clarity and growth guidance for its gross profit sharing exclusive and non-exclusive agreement in select markets with MDS, a subsidiary of Medbox, Inc. Under the terms of the agreement Cannabis Science has a 50/50 gross profit exclusive on any and all MDS equipment sales in Canada and other select markets. Both CBIS and MDS have multiple opportunities in Canada based on recent developments with medical cannabis in that market. Other countries will follow pursuant to the agreement as CBIS moves forward aggressively in Europe and South America.
Medical Marijuana Payment Provider Gets $1.1 Million from Unnamed Private-Equity Firm: MediSwipe Inc. (OTCQB: MWIP), Cannabis Science Inc. (NASDAQ OTC: CBIS), Medical Marijuana Inc. (OTC PINK: MJNA), Growlife Inc. (OTCBB: PHOT)
ACCESSWIRE - Thu Jan 30, 8:44AM CST
Mystery, anticipation and anonymity continue to surround the medical and recreational marijuana industries, especially when it comes to penny stocks.
